Riskpilot← Back to searchSign inGet full accessAmber Rays AB
ABDissolvedOrg 5592415250LundMedical specialists activities · NACE 8622Est. 20200 employees
Revenue 2024
SEK 335K
-87% vs 2023
EBITDA margin
-10.1%
-104% vs 2023
Equity ratio
90.5%
Financial strength
Net profit 2024
SEK -36K
-106% vs 2023
| Revenue | SEK 335K | -87% |
| EBITDA | SEK -34K | -104% |
| Net profit | SEK -36K | -106% |
| Total assets | SEK 672K | -21% |
| Equity | SEK 608K | -6% |
| Employees | 0 | — |
Legal name
Amber Rays AB
Org number
5592415250
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Aktiebolaget ska bedriva uthyrning av läkartjänster inom sluten- och primärvård. Konsultationer inom röntgendiagnostik. Utveckling och testing av Data och IT. Handel inom smyckesindustrin och sminkprodukter. Vidare skall bolaget äga och förvalta fastigheter och värdepapper och därmed förenlig verksamhet.
Address
Lund
Email
info@bolagspartner.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 646 | 2 024 | 2 442 | 2 588 | 335 |
| Staff expenses | — | — | −1 531 | −1 650 | −318 |
| EBITDA | 335 | 426 | 537 | 772 | −34 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 335 | 426 | 537 | 772 | −34 |
| Net financials | — | — | −1 | −3 | −2 |
| Profit before tax | 335 | 426 | 536 | 769 | −36 |
| Tax | −72 | −88 | −111 | −159 | — |
| Net profit | 263 | 338 | 425 | 610 | −36 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 423 | 828 | 766 | 846 | 672 |
| Equity | 288 | 449 | 454 | 644 | 608 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 135 | 379 | 312 | 202 | 64 |
| Total debt | 135 | 379 | 312 | 202 | 64 |
EBITDA margin
-10.1%
This company
15.8%
Market median
-164% vs market
20202024
Equity ratio
90.5%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
-6.0%
This company
18.4%
Market median
-133% vs market
20202024
Net profit margin
-10.8%
This company
8.1%
Market median
-233% vs market
20202024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Amber Rays AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kaesar Abdul-Hassan Abdul-Hussaen | Board of Directors | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |
| Tamara Saad Abdul Malik | Deputy Board Member | 0 companies |